New Calcium Channel Discovery Opens Door to Brain Disorder Treatments

Researchers at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) have uncovered a molecular lever mechanism regulating the N-type voltage-gated calcium channel (CaV2.2), according to a study published in the July 2026 issue of the Proceedings of the National Academy of Sciences. Led by Professor Byung Chang Suh of the Department of Brain Sciences, the research team found that a specific region of the channel’s I–II loop bends to act as a lever, altering the channel’s structure based on the type of bound beta subunit. This discovery provides foundational insights for developing therapeutics for intractable brain disorders like Alzheimer’s disease and epilepsy.

How the Molecular Lever Controls Calcium Channels

Neurons rely on the conversion of electrical signals into chemical signals to transmit information across the brain. A critical step in this neural communication is the influx of calcium ions through voltage-gated calcium channels. According to DGIST, the duration these channels remain open depends directly on the type of beta subunit—an auxiliary protein—that binds to them. Until now, the exact structural alterations caused by these subunits remained unknown.

Through comparative analysis of multiple beta-subunit models, Professor Suh’s team identified that residue R370 at the beginning of the channel’s I–II loop is unusually bent. This loop pivots around R370, functioning as a molecular lever that changes the channel structure at varying angles. Electrophysiological measurements and kinetic modeling confirmed that these structural shifts dictate whether the channel is open or closed, directly impacting neural signal transmission.

Implications for Treating Intractable Brain Disorders

Calcium channel dysregulation is tied to a wide array of severe neurological conditions. By mapping out how beta-subunit binding alters channel architecture, the DGIST team has provided a foundation for drug discovery. According to the researchers, this newly revealed mechanism opens pathways for treating neuropathic pain, epilepsy, autism spectrum disorder, and Alzheimer’s disease.

“Through this study, we clearly elucidated the long-standing question of how beta-subunit binding induces dynamic and structural changes in calcium channels,” Professor Suh stated regarding the findings. The research was supported by the Basic Research Laboratory, Leading Brain Science Convergence Technology Development, and Core Individual Basic Research programs.

Frequently Asked Questions

What is the N-type voltage-gated calcium channel (CaV2.2)?

CaV2.2 is a calcium channel that plays a critical role in neural signal transmission by allowing calcium ions to flow into neurons, helping convert electrical signals into chemical ones.

What did the DGIST research team discover?

Led by Professor Byung Chang Suh, the team discovered a molecular lever mechanism—specifically located at residue R370 on the I–II loop—that dictates how auxiliary beta subunits alter the structure and opening time of calcium channels.

Which brain disorders could benefit from this research?

According to DGIST, the discovery paves the way for potential therapeutics targeting intractable conditions including neuropathic pain, epilepsy, autism spectrum disorder, and Alzheimer’s disease.